Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02098343
Title p53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer, a Phase Ib/II Study of Systemic Carboplatin Combination Chemotherapy With or Without APR-246
Recruitment Completed
Gender female
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Aprea Therapeutics AB
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | SWE | NLD | GBR | FRA | ESP | DEU | BEL

Additional content available in CKB BOOST